Breathe Well Live Well
|
FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for …
PR Newswire (press release) "We are excited about the prospect of advancing PL-3994 into a Phase 2A human trial to treat asthma patients," stated Dr. Carl Spana, Palatin's Chief Executive Officer. "Existing therapies for acute exacerbations of asthma in patients unresponsive to … |
View full post on asthma – Google News
|
Targacept Begins Phase 2 Studies of TC-6987 in Asthma and Type 2 Diabetes
Trading Markets (press release) TC-6987 demonstrated a potent anti-inflammatory response in a variety of preclinical studies conducted by Targacept, including models of asthma and diabetes … |
View full post on asthma – Google News
|
Targacept initiates two anti-inflammatory drug studies
Pharmaceutical Business Review Targacept has initiated two separate Phase II studies of its product candidate TC-6987 in disorders characterised by inflammation, in asthma and Type II … Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes Targacept starts new trial for diabetes drug TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … |
View full post on asthma – Google News
|
Targacept Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and …
EON: Enhanced Online News (press release) TC-6987 demonstrated a potent anti-inflammatory response in a variety of preclinical studies conducted by Targacept, including models of asthma and diabetes … Targacept to begin phase 2 trials for its anti-inflammatory drug compound Targacept starts new trial for diabetes drug |
View full post on asthma – Google News
|
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and …
4-traders (press release) TC-6987 demonstrated a potent anti-inflammatory response in a variety of preclinical studies conducted by Targacept, including models of asthma and diabetes … |
View full post on asthma – Google News
|
Targacept Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and …
Genetic Engineering News (press release) TC-6987 demonstrated a potent anti-inflammatory response in a variety of preclinical studies conducted by Targacept, including models of asthma and diabetes … |
View full post on asthma – Google News
|
What Have We Learned From European Birth Cohort Studies?
Internal Medicine News Digital Network LONDON – Food allergy is most commonly linked to hen's eggs in Berlin, breastfeeding protects against the development of asthma, and both asthma and atopic … |
View full post on asthma – Google News
|
Achieve Clinical Research Announces Asthma Research Studies in Birmingham, Alabama
PR.com (press release) "Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with asthma," says Hayes … |
View full post on asthma – Google News
|
Consanguinity key cause of asthma, reveal studies
Khaleej Times DUBAI — Consanguinity puts Emirati children at a higher risk of developing asthma and co-related allergies, according to local studies released recently. … |
View full post on asthma – Google News
|
Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM …
MarketWatch (press release) Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD. The findings, presented at the … Clinical Data Reveals Positive Results From Early-stage Trials Of Stedivaze … |
View full post on asthma – Google News